Comparison of Intra-articular Steroid Injection and Radiofrequency Thermocoagulation in Coxarthrosis Patients

Sponsor
Istanbul University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05564065
Collaborator
(none)
40
1
2
16
2.5

Study Details

Study Description

Brief Summary

The investigators aimed that the Comparison of effectiveness of the intra-articular steroid injection and radiofrequency thermocoagulation of the sensory branches of the femoral and obdurator nerves in coxarthrosis patients

Condition or Disease Intervention/Treatment Phase
  • Procedure: Radiofrequency thermocoagulation of sensory branches of hip joint
  • Procedure: Intraarticular steroid injection of hip joint
N/A

Detailed Description

Osteoarthirtis is a deficency of articular cartilge which is caused by genetic, metabolic and biochemical factors. This is a pathologic period with cartilage, bone and sinovium destruction.

Pharmacological treatments and/or phsiycal medicine may not be enough to reduce pain in patients with chronic pain of osteoarthiritis. Intraarticular steroid injection is the most common used intervention method in analgesia of hip osteoarthirtis. Thus; cartilage inflammation can be decelerated and osteophyte formation can be prevented. On the other hand; because of less vascularity of hip joint, frequent steroid injections may cause aseptic necrosis.

In past decades, treatment to pain of hip joint pain caused by ostheoarthrits, radiofrequency ablation treatment is used to sensory nerves which cause pain. Especially, it can be a solution in patients who do not want to undergo a surgery.

Patients diagnosed with coxarthrosis will be randomly divided into two groups. One group will receive intra-articular steroid injection and the other group will receive radiofrequency thermocoagulation to the hip sensory nerve branches (femoral and obdurator). It was planned to compare the vas scores of the patients before and 1-3 months after the procedure with their effectiveness.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Two groups: 1. intraarticular steroid injection of hip joint; 2. Radiofrequency thermocoagulation of femoral and obturator nerve terminal sensory branches of hip jointTwo groups: 1. intraarticular steroid injection of hip joint; 2. Radiofrequency thermocoagulation of femoral and obturator nerve terminal sensory branches of hip joint
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Comparison of Intra-articular Steroid Injection and Radiofrequency Thermocoagulation of the Sensory Branches of the Femoral and Obdurator Nerves in Coxarthrosis Patients
Actual Study Start Date :
Aug 1, 2021
Anticipated Primary Completion Date :
Nov 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Radiofrequency thermocoagulation of sensory branches of hip joint

There are two main nerves that carry the pain sensation of the hip joint. These nerves are the femoral and obturator nerves. The sensory branches of these nerves going to the hip joint will be detected with a radiofrequency device under fluoroscopy and percutaneous ablation will be performed.

Procedure: Radiofrequency thermocoagulation of sensory branches of hip joint
There are two main nerves that carry the pain sensation of the hip joint. These nerves are the femoral and obturator nerves. The sensory branches of these nerves going to the hip joint will be detected with a radiofrequency device under fluoroscopy and percutaneous ablation will be performed.

Active Comparator: Intraarticular steroid injection of hip joint

Fluoroscopy guided percutaneous intra articular steroid injection of hip joint will be performed

Procedure: Intraarticular steroid injection of hip joint
Fluoroscopy guided percutaneous intra articular steroid injection of hip joint will be performed

Outcome Measures

Primary Outcome Measures

  1. Visual Analog Scale comparison [Baseline]

    VAS is the most common pain scale. Using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity.

  2. Visual Analog Scale comparison [1.month]

    VAS is the most common pain scale. Using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity.

  3. Visual Analog Scale comparison [3.month]

    VAS is the most common pain scale. Using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
    • Older than 18-year-old
  • Clincal, radiological (Grade 3-4) and laboratory examinations ara related with diagnosis of hip joint osteoarthirtis

  • Despite of previous medical and physical treatment, VAS score > 5 and above

  • Norological examination without critical motor and sensory deficency

  • Patients who sign informed consent.

Exclusion Criteria:
  • Coagulation disorders (bleeding diathesis)

  • Usage of antitrombotic, anticoagulant medications

  • Sepsis and local infection on intervention area

  • Allergic to any of drugs which is used in intervention

  • Without informed consent approval

Contacts and Locations

Locations

Site City State Country Postal Code
1 Halil Cetingok Istanbul Fatih Turkey 34093

Sponsors and Collaborators

  • Istanbul University

Investigators

  • Study Director: Halil Cetingok, Ass. Prof, Istanbul University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Halil Cetingok, Assistant professor, Istanbul University
ClinicalTrials.gov Identifier:
NCT05564065
Other Study ID Numbers:
  • 2019/123
First Posted:
Oct 3, 2022
Last Update Posted:
Oct 3, 2022
Last Verified:
Sep 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 3, 2022